Synthomer plc (LON:SYNT – Get Free Report) shot up 11% during mid-day trading on Friday . The stock traded as high as GBX 92.15 ($1.21) and last traded at GBX 88.16 ($1.15). 11,893,332 shares changed hands during mid-day trading, an increase of 1,243% from the average session volume of 885,594 shares. The stock had previously closed at GBX 79.40 ($1.04).
Wall Street Analyst Weigh In
Separately, Berenberg Bank cut Synthomer to a “hold” rating and lowered their target price for the stock from GBX 230 ($3.01) to GBX 150 ($1.96) in a research note on Wednesday, March 12th.
Check Out Our Latest Report on SYNT
Synthomer Trading Down 6.7 %
Synthomer (LON:SYNT – Get Free Report) last announced its quarterly earnings results on Wednesday, March 12th. The company reported GBX (3.50) (($0.05)) earnings per share (EPS) for the quarter. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%. As a group, equities analysts expect that Synthomer plc will post 12.962963 earnings per share for the current fiscal year.
About Synthomer
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
Read More
- Five stocks we like better than Synthomer
- What Makes a Stock a Good Dividend Stock?
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- 3 Warren Buffett Stocks to Buy Now
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.